Equity ETFs Pfizer Acquires Anacor, Reviving M&A Bets in Biotech Sector, ETFs By Max ChenMay 16, 2016
Equity ETFs Health Care ETFs Can Still Strengthen on Increased M&A Activity By Max ChenApril 28, 2016
Equity ETFs Silver Lining for Biotechnology ETFs After Pfizer Calls off Allergan Deal By Max ChenApril 6, 2016
Contributed ETF Chart of the Day: Biotechnology Breakthroughs By Paul Weisbruch, Street One FinancialJuly 31, 2015
Contributed ETF Chart of the Day: Hot Biotechnology Sector By Paul Weisbruch, Street One FinancialJuly 30, 2015
Featured M&A Activity Will Support Pharma ETFs Through Rising Rate Environment By Tom LydonJuly 9, 2015
